Nath Bio-Genes (India) Ltd

AI
Nath Bio-Genes Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Nath Bio-Genes (India) Ltd

₹ 140 0.18%
05 Oct 9:25 a.m.
nathbiogenes.com BSE: 537291 NSE: NATHBIOGEN
About

Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]

Key Points

Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into

Website BSE NSE
  • Market Cap ₹ 266 Cr.
  • Current Price ₹ 140
  • High / Low ₹ 207 / 126
  • Stock P/E 7.86
  • Book Value ₹ 358
  • Dividend Yield 1.43 %
  • ROCE 7.10 %
  • ROE 5.47 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.39 times its book value
  • Debtor days have improved from 110 to 70.0 days.

Cons

  • Tax rate seems low
  • Company has a low return on equity of 5.93% over last 3 years.
  • Contingent liabilities of Rs.89.3 Cr.
  • Earnings include an other income of Rs.15.2 Cr.
  • Dividend payout has been low at 9.52% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
235 23 32 43 244 32 37 52 284 44 66 52 328
198 18 26 39 207 27 29 52 254 38 62 47 293
Operating Profit 37 5 6 4 37 5 8 0 29 6 4 4 35
OPM % 16% 22% 18% 9% 15% 15% 22% 0.8% 10% 14% 5% 9% 11%
0 0 3 1 0 0 0 4 4 4 4 4 3
Interest 3 2 3 1 2 3 4 1 3 4 5 5 4
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 34 2 5 3 34 1 4 2 29 5 2 2 33
Tax % 1% 19% 17% 19% 1% -3% 30% 30% 2% 12% 35% 100% 2%
33 2 4 3 33 1 3 1 28 5 2 -0 32
EPS in Rs 17.59 0.79 2.02 1.38 17.55 0.58 1.39 0.78 14.88 2.54 0.84 -0.01 16.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
97 109 230 234 248 268 445 490
82 89 193 185 198 217 393 440
Operating Profit 15 20 37 49 50 51 52 49
OPM % 15% 18% 16% 21% 20% 19% 12% 10%
1 1 -87 1 4 4 14 15
Interest 2 4 11 10 9 11 16 17
Depreciation 5 5 3 3 3 4 4 4
Profit before tax 9 12 -63 36 42 41 46 43
Tax % -1% 4% 6% 3% 5% 5% 10%
9 12 -67 35 40 39 42 39
EPS in Rs 5.75 7.34 -35.46 18.43 20.85 20.31 21.91 20.35
Dividend Payout % 0% 0% -6% 11% 10% 10% 9%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 24%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 1%
TTM: 9%
Stock Price CAGR
10 Years: 2%
5 Years: -16%
3 Years: -13%
1 Year: -17%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 6%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 16 16 19 19 19 19 19
Reserves 30 41 523 554 591 625 661
11 19 93 105 110 123 138
63 82 105 114 160 259 278
Total Liabilities 120 158 739 793 880 1,026 1,097
21 38 245 244 249 250 249
CWIP 0 0 0 0 0 0 0
Investments 1 0 5 5 6 6 6
99 121 490 543 625 770 842
Total Assets 120 158 739 793 880 1,026 1,097

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
17 38 75 18 -13
-20 -3 -27 -4 3
-22 -2 -8 -2 -4
Net Cash Flow -25 34 39 11 -13
Free Cash Flow 16 36 48 10 -16
CFO/OP 54% 80% 150% 37% -22%

Ratios

Consolidated / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 47 70 136 152 139 121 70
Inventory Days 587 667 4,388
Days Payable 146 239 586
Cash Conversion Cycle 487 499 136 3,954 139 121 70
Working Capital Days 79 64 427 415 342 321 253
ROCE % 24% 7% 7% 7% 7%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cotton Bt Volume
lakh packets ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Paddy Volume
quintals ・Standalone data
Number of Distributors/Dealers
count ・Standalone data
Plant Nutrition Volume
litres ・Standalone data
Storage Capacity
MT ・Standalone data
Cotton + Paddy Combined Revenue Share
% of revenue ・Standalone data
Vegetable Seeds Volume
quintals ・Standalone data
Maize Volume
quintals ・Standalone data
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59%
0.22% 0.32% 0.27% 0.21% 0.18% 0.19% 0.21% 0.41% 0.32% 0.31% 0.22% 0.26%
4.37% 4.37% 4.37% 4.37% 4.37% 4.37% 3.94% 2.25% 0.76% 0.01% 0.01% 0.01%
49.81% 49.72% 49.76% 49.80% 49.83% 49.83% 50.24% 51.73% 53.31% 54.08% 54.17% 54.13%
No. of Shareholders 34,36534,26335,13235,83435,42335,05634,91134,20734,12233,55033,03132,564

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls